These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31648685)
1. Research Techniques Made Simple: An Introduction to Drug Discovery for Dermatology. Bell M; Webster L; Woodland A J Invest Dermatol; 2019 Nov; 139(11):2252-2257.e1. PubMed ID: 31648685 [TBL] [Abstract][Full Text] [Related]
2. Mitigating risk in academic preclinical drug discovery. Dahlin JL; Inglese J; Walters MA Nat Rev Drug Discov; 2015 Apr; 14(4):279-94. PubMed ID: 25829283 [TBL] [Abstract][Full Text] [Related]
3. Research Techniques Made Simple: Molecular Docking in Dermatology - A Foray into In Silico Drug Discovery. Issa NT; Badiavas EV; Schürer S J Invest Dermatol; 2019 Dec; 139(12):2400-2408.e1. PubMed ID: 31753122 [TBL] [Abstract][Full Text] [Related]
4. Revisiting Repurposing. Sharlow ER Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703 [TBL] [Abstract][Full Text] [Related]
5. Applications of chemogenomic library screening in drug discovery. Jones LH; Bunnage ME Nat Rev Drug Discov; 2017 Apr; 16(4):285-296. PubMed ID: 28104905 [TBL] [Abstract][Full Text] [Related]
6. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery? Sahu NU; Kharkar PS Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717 [TBL] [Abstract][Full Text] [Related]
7. Meeting the demands of regulatory requirements: the significance of ADME. Guttendorf R Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021 [No Abstract] [Full Text] [Related]
8. Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioning. Datti A Drug Discov Today; 2023 May; 28(5):103522. PubMed ID: 36764576 [TBL] [Abstract][Full Text] [Related]
9. In vitro screening for drug repositioning. Wilkinson GF; Pritchard K J Biomol Screen; 2015 Feb; 20(2):167-79. PubMed ID: 25527136 [TBL] [Abstract][Full Text] [Related]
10. The value of drug repositioning in the current pharmaceutical market. Tobinick EL Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170 [TBL] [Abstract][Full Text] [Related]
11. Drug repositioning summit: finding new routes to success. Campas C Drug News Perspect; 2009 Mar; 22(2):126-8. PubMed ID: 19330171 [TBL] [Abstract][Full Text] [Related]
12. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models. Chung TD Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951 [TBL] [Abstract][Full Text] [Related]
13. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575 [TBL] [Abstract][Full Text] [Related]
14. Food and drug administration approval process for dermatology drugs in the United States. Boozalis E; Semenov YR; Kwatra SG J Dermatolog Treat; 2018 Sep; 29(6):536-538. PubMed ID: 29304565 [TBL] [Abstract][Full Text] [Related]
15. Serendipity in Cancer Drug Discovery: Rational or Coincidence? Prasad S; Gupta SC; Aggarwal BB Trends Pharmacol Sci; 2016 Jun; 37(6):435-450. PubMed ID: 27083322 [TBL] [Abstract][Full Text] [Related]
16. The prince and the pauper. A tale of anticancer targeted agents. Dueñas-González A; García-López P; Herrera LA; Medina-Franco JL; González-Fierro A; Candelaria M Mol Cancer; 2008 Oct; 7():82. PubMed ID: 18947424 [TBL] [Abstract][Full Text] [Related]
17. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Jin G; Wong ST Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728 [TBL] [Abstract][Full Text] [Related]
18. Introduction. Can comparative effectiveness research help tame rising health care costs? Brixner DI J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S05. PubMed ID: 22663292 [No Abstract] [Full Text] [Related]
19. Drug Repositioning and Target Finding Based on Clinical Evidence. Kaneko S; Nagashima T Biol Pharm Bull; 2020; 43(3):362-365. PubMed ID: 32115497 [TBL] [Abstract][Full Text] [Related]
20. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis. Janes J; Young ME; Chen E; Rogers NH; Burgstaller-Muehlbacher S; Hughes LD; Love MS; Hull MV; Kuhen KL; Woods AK; Joseph SB; Petrassi HM; McNamara CW; Tremblay MS; Su AI; Schultz PG; Chatterjee AK Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10750-10755. PubMed ID: 30282735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]